Are We Making Progress in Lung Cancer Using Progression-Free Survival as a Surrogate End Point?

JAMA Oncol. 2015 May;1(2):202-3. doi: 10.1001/jamaoncol.2015.0407.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / economics*
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Decision Support Techniques*
  • Eligibility Determination / economics*
  • Health Care Costs*
  • Health Services Accessibility / economics*
  • Humans
  • Lung Neoplasms / economics*
  • Lung Neoplasms / therapy*
  • Patient Selection*
  • Process Assessment, Health Care / economics*